Syneos Health Logo (WIPO, 22.12.2017)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke Syneos Health wurde als Bildmarke am 22.12.2017 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Zeichen, Notationen, Symbole #Briefe, die eine besondere Form des Schreibens darstellen #Symbol der Unendlichkeit #Buchstabenreihen in verschiedenen Dimensionen
| Markenform | Bildmarke |
| Aktenzeichen | 1416188 |
| Länder | 
|
| Basismarke |
Nr. 87717521,
12. Dezember 2017
|
| Anmeldedatum | 22. Dezember 2017 |
| Ablaufdatum | 22. Dezember 2027 |
Markeninhaber
1030 Sync Street
Morrisville NC 27560
US
Morrisville NC 27560
US
Markenvertreter
P.O. Box 64807
Chicago IL 60664-0807
US
Waren und Dienstleistungen
35
Strategic business consulting, marketing and advertising,
public relations communications strategy, information and
data collection, and data analytics, all in the
pharmaceutical, biotechnology and life sciences fields
(terms considered too vague by the International Bureau -
rule 13 (2) (b) of the Common Regulations); sales promotion
services; market analysis and research services; personnel
recruitment and placement; recruitment services, namely,
advertising clinical trials, recruiting patients, and
placing patients for participation in clinical trials for
testing of pharmaceuticals and devices; consulting in sales
techniques and sales programs; sales volume tracking for
others, all in the pharmaceutical, biotechnology and life
sciences fields; business consulting in the field of
clinical trials, namely, clinical data and regulatory
submission management on behalf of medical, pharmaceutical
and biotechnology companies to assist them with clinical
research, clinical trials and applications for drug
approval
41
Education and training services in the field of
pharmaceutical sales; providing on-line, non-downloadable
newsletters and bulletins in the pharmaceutical,
biotechnology and life sciences fields; educational services
in the field of clinical trials, namely, webinars, videos,
articles, white papers, and podcasts
42
Medical, scientific and data analysis research services for
others, namely, conducting and analyzing clinical trials in
the pharmaceutical, biotechnology and life sciences fields;
pharmaceutical drug development services, namely, developing
clinical trial methodologies; consulting services in the
area of pharmaceutical clinical testing; extended clinical
research services for others, namely, computerized data
management of clinical trials, biostatistical analysis,
environmental consultancy, preclinical research and
development evaluation, repairing flawed clinical trials and
dossiers, strategic clinical research portfolio management,
and biosurveillance monitoring; providing life science and
scientific research information to physicians and other
health care professionals, patients, and medical,
pharmaceutical and biotechnology companies; assist
pharmaceutical and biotechnology companies with applications
for drug approval (terms considered too vague by the
International Bureau - rule 13 (2) (b) of the Common
Regulations); provide regulatory compliant technical writing
services in the field of medical research and clinical
studies; consulting services in the field of contract
clinical research and contract product development; Internet
development, design and consulting services for others,
namely, creating websites featuring blogs about medical and
pharmaceutical information related to chronic illnesses and
disease, creating an online community for patients and
caregivers to communicate about healthcare, and design and
development of interactive software for use in the
communication and dissemination of medical and
pharmaceutical information
44
Providing medical information to physicians, other health
care professionals and for medical patients; promoting
health information through direct-to-patient communications
to promote patient adherence
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 05. Dezember 2020 | 2021/1 Gaz | PH | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 13. Mai 2020 | 2020/27 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 21. März 2020 | 2020/21 Gaz | MX | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 03. Februar 2020 | 2020/6 Gaz | BG | Ablehnung |
| 22. November 2019 | 2020/1 Gaz | CH | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 21. November 2019 | 2019/49 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 13. November 2019 | 2019/49 Gaz | US | RAW: Partial Ceasing Effect |
| 07. November 2019 | 2019/45 Gaz | SE | Ablehnung |
| 28. Oktober 2019 | 2019/44 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 03. Oktober 2019 | 2019/43 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 01. Oktober 2019 | 2019/40 Gaz | NZ | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 28. September 2019 | 2019/42 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 16. Juli 2019 | 2019/29 Gaz | VN | Ablehnung |
| 16. Juli 2019 | 2019/29 Gaz | UA | Ablehnung |
| 05. Juli 2019 | 2019/28 Gaz | IT | Ablehnung |
| 04. Juli 2019 | 2019/27 Gaz | JP | Ablehnung |
| 27. Juni 2019 | 2019/27 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 29. Mai 2019 | 2019/22 Gaz | MX | Ablehnung |
| 29. Mai 2019 | 2019/23 Gaz | CH | Ablehnung |
| 01. Mai 2019 | 2019/19 Gaz | KR | Ablehnung |
| 12. April 2019 | 2019/20 Gaz | ES | Ablehnung |
| 09. April 2019 | 2019/20 Gaz | RS | Ablehnung |
| 20. März 2019 | 2019/13 Gaz | SE | Ablehnung |
| 18. März 2019 | 2019/12 Gaz | TR | Ablehnung |
| 08. März 2019 | 2019/11 Gaz | CZ | Ablehnung |
| 06. März 2019 | 2019/10 Gaz | HU | Ablehnung |
| 26. Februar 2019 | 2019/10 Gaz | RU | Ablehnung |
| 25. Februar 2019 | 2019/9 Gaz | IN | Ablehnung |
| 18. Februar 2019 | 2019/9 Gaz | IL | Ablehnung |
| 18. Februar 2019 | 2019/8 Gaz | FR | Ablehnung |
| 29. Januar 2019 | 2019/5 Gaz | RO | Ablehnung |
| 18. Januar 2019 | 2019/15 Gaz | AU | Ablehnung |
| 14. Januar 2019 | 2019/4 Gaz | CN | Ablehnung |
| 08. Januar 2019 | 2019/2 Gaz | EM | Ablehnung |
| 20. Dezember 2018 | 2018/51 Gaz | DE | Ablehnung |
| 18. Dezember 2018 | 2018/51 Gaz | CO | Ablehnung |
| 14. Dezember 2018 | 2018/51 Gaz | PL | Ablehnung |
| 14. November 2018 | 2018/46 Gaz | GB | Ablehnung |
| 23. Oktober 2018 | 2018/44 Gaz | SG | Ablehnung |
| 15. Oktober 2018 | 2018/42 Gaz | BX | Ablehnung |
| 24. August 2018 | 2018/39 Gaz | NZ | Ablehnung |
| 23. August 2018 | 2018/35 Gaz | PH | Ablehnung |
| 22. Dezember 2017 | 2018/29 Gaz | US | Eintragung |
ID: 141416188